First Quarter Financial Report

Written by Kristin Hart | May 15, 2018 5:15:11 AM
Moss, 15 May 2018
Gentian Diagnostics AS announces its results for the first quarter of 2018. The highlights include
  • Record level for total operating revenue of MNOK 11.2 for the quarter
  • 100 % growth in sales revenue compared to 1Q17
  • 24 % growth in sales revenue compared to 4Q17
  • Strong sales for both Cystatin C and fCal
  • New Proof-of-Concept announced post end of quarter

Please find the report enclosed. The report will also be made available on www.gentian.com.

 
For further information, please contact:
Bård Sundrehagen CEO, Gentian Diagnostics
E-mail: bard.sundrehagen@gentian.no
Cell Phone: +47 924 14 117
 
Njaal Kind CFO, Gentian Diagnostics
E-mail: njaal.kind@gentian.no
Cell Phone: +47 919 06 525
 
 
MeldingsID:  451378
 
 
Vedlegg: GD 1Q2018 report VF
View full post